Matrix Metalloproteinases (MMPs) are a family of enzymes that are attracting growing interest as therapeutic targets. They are proteases whose fundamental role has been recognised in the degradation of the Extracellular Matrix (ECM) components. Their expression is finely regulated at many levels (transcription, activation, inhibition) while unregulated profiles have been found in many pathological conditions such as cancer, arthritis, atherosclerosis, and inflammatory diseases. Since the use of endogenous inhibitors is not easy to accomplish, the design and synthesis of new small molecules that could allow the regulation of these proteins is an avanguard in nowadays research of new anticancer drugs, as well as for other therapies. The research project of my PhD thesis focused mainly on four topics:  Synthesis and biological evaluation of arylsulfones and thioaryl derivatives bearing alternative zinc-binding groups as MMP-12 inhibitors  Synthesis and biological evaluation of new sugar-based arylsulfonamide carboxylates as MMP- 12 inhibitors with improved water solubility  Synthesis and biological evaluation of bifunctional ligands of MT1-MMP  Biological evaluation of selective ADAM-10 inhibitors able to inhibit DDR1 and DDR2 shedding

Design, Synthesis and Development of Hit Compounds able to Modulate some Bio-Pharmacological Activities of Metalloenzymes Involved in Degenerative Diseases

CUFFARO, DORETTA
2018

Abstract

Matrix Metalloproteinases (MMPs) are a family of enzymes that are attracting growing interest as therapeutic targets. They are proteases whose fundamental role has been recognised in the degradation of the Extracellular Matrix (ECM) components. Their expression is finely regulated at many levels (transcription, activation, inhibition) while unregulated profiles have been found in many pathological conditions such as cancer, arthritis, atherosclerosis, and inflammatory diseases. Since the use of endogenous inhibitors is not easy to accomplish, the design and synthesis of new small molecules that could allow the regulation of these proteins is an avanguard in nowadays research of new anticancer drugs, as well as for other therapies. The research project of my PhD thesis focused mainly on four topics:  Synthesis and biological evaluation of arylsulfones and thioaryl derivatives bearing alternative zinc-binding groups as MMP-12 inhibitors  Synthesis and biological evaluation of new sugar-based arylsulfonamide carboxylates as MMP- 12 inhibitors with improved water solubility  Synthesis and biological evaluation of bifunctional ligands of MT1-MMP  Biological evaluation of selective ADAM-10 inhibitors able to inhibit DDR1 and DDR2 shedding
2-feb-2018
Italiano
dimers
glycoconjugates
MMP inhibitors
MMPs
Rossello, Armando
Bertoli, Alessandra
File in questo prodotto:
File Dimensione Formato  
1.SUMMARYokk.pdf

accesso aperto

Dimensione 396.55 kB
Formato Adobe PDF
396.55 kB Adobe PDF Visualizza/Apri
2.Introduction.pdf

Open Access dal 06/02/2024

Dimensione 1.88 MB
Formato Adobe PDF
1.88 MB Adobe PDF Visualizza/Apri
Attivit_didattiche.pdf

non disponibili

Dimensione 364.21 kB
Formato Adobe PDF
364.21 kB Adobe PDF
Chapter_2_MMP_12.pdf

Open Access dal 06/02/2024

Dimensione 3.07 MB
Formato Adobe PDF
3.07 MB Adobe PDF Visualizza/Apri
Chapter_3_MT1MMP.pdf

Open Access dal 06/02/2024

Dimensione 1.47 MB
Formato Adobe PDF
1.47 MB Adobe PDF Visualizza/Apri
Chapter_4_ADAM_10.pdf

Open Access dal 06/02/2024

Dimensione 1.49 MB
Formato Adobe PDF
1.49 MB Adobe PDF Visualizza/Apri

I documenti in UNITESI sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.14242/144123
Il codice NBN di questa tesi è URN:NBN:IT:UNIPI-144123